North America Needle Market is expected to grow from USD 2.65 billion in 2023 to USD 3.88 billion by 2030, registering a CAGR of 7.9 % during the forecast period ranging from 2025 to 2030.

Published Date: Jul, 2024

The North American Needles Market is projected to grow from USD 2.65 billion in 2023 to USD 3.88 billion by 2030, with a CAGR of 7.9%.

The different market segments include by type led by the safety needles subsegment, by product led by the suture needles subsegment, by material led by the stainless steel needles subsegment, by delivery mode led by the hypodermic needles subsegment, and by end users led by the hospitals and diagnostic centers subsegment due to varied reasons.

The market growth is driven by a lot of significant factors which includes but not limited to growing adoption and prevalence for needle-free systems, development of safer needle designs, and sustainability practices, as well as ongoing technological advancements, higher healthcare expenditure, and increasing immunization initiatives.

The regions holding a significant share of the North American needles market and contributing to its growth include the US, Canada, and Mexico. The US market will grow due to its robust healthcare infrastructure and prevalence of chronic diseases, while the Canadian market expansion will be the result of the rising healthcare expenditure and home healthcare penchant. On the other hand, the Mexican market has a high growth potential due to improving healthcare infrastructure and rising medical tourism.

The notable market players include Becton, Dickinson and Company (BD), Cardinal Health Inc., Medtronic plc, and others. Their focus on innovation and launches of safer needles drives market expansion. A couple of the noteworthy developments by the key players include the acquisition of the patient care division of Medtronic by Cardinal Health Inc and the FDA approval received by MTD Group for DropSafe Sicura injection needle for safer therapeutic injections.

Browse 62 market data Tables and 38 Figures spread through 95 Pages and in-depth TOC on North America Needle Market By Type (Conventional Needles, Safety Needles, Bevel Needles, Blunt Fill Needles, Filter Needles, Vented Needles, Active Needles and Passive Needles), By Product (Suture, Blood Collection, Ophthalmic, Dental, Insufflation, Pen and Other), By Material (Hypodermic, Intravenous, Intramuscular and Intraperitoneal), By Delivery Mode (Glass, Plastic, Stainless, Polyether Ether Ketone), By End User (Hospitals, Diagnostic Centers, Home Healthcare and Others) and By Geography (US, Canada, Mexico) - Global Forecast from 2025 to 2030.

North America Needle Market Segmentation and Key Players

Segment / Key Players

Categorization

Type

Conventional Needles, Safety Needles, Bevel Needles, Blunt Fill Needles, Filter Needles, Vented Needles, Active Needles and Passive Needles

Product

Suture, Blood Collection, Ophthalmic, Dental, Insufflation, Pen and Other

Material

Hypodermic, Intravenous, Intramuscular and Intraperitoneal

Delivery Mode

Glass, Plastic, Stainless, Polyether Ether Ketone

End User

Hospitals, Diagnostic Centers, Home Healthcare and Others

Key Players

Becton, Dickinson and Company (BD), Cardinal Health Inc, Medtronic plc, MTD Group, Smiths Medical, B. Braun Medical Inc, Nipro Medical Corporation, Retractable Technologies Inc, Hologic Inc, Henry ScheinInc, and ICU Medical Inc, to name a few.

By type, safety needles dominate the north america needle market

The safety needles segment is expected to grow at a higher CAGR due to higher adoption in healthcare sector for its safety features and lower risks of injuries and infections.

"US is projected to register the fastest CAGR during the forecast period, i.e., 2025-2030 in the north america needle market.”

The US market will grow due to its developed healthcare infrastructure, growing aging population, and higher prevalence of chronic diseases such as diabetes, along with a growing emphasis on research and development of advanced needle technologies.

The major players of the North America needle market are Becton, Dickinson and Company (BD), Cardinal Health Inc, Medtronic plc, MTD Group, Smiths Medical, B. Braun Medical Inc, Nipro Medical Corporation, Retractable Technologies Inc, Hologic Inc, Henry ScheinInc, and ICU Medical Inc.

Recent Developments By the Key Players

B. Braun Inc. (A leader in smart infusion therapy and pain managementcompany) has launched its new Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection, 1,000 milliliters. This has served the diverse needs of health care facilities and their patients for this high-alert medication as Heparin portfolio is manufactured using EXCEL IV Containers which are not made with natural rubber latex, DEHP or PVC, placing a priority on patient and environmental safety. 

Nipro Medical Corp. has built USD 398M North Carolina plant. Greenville (The Japan-based medical device maker) shall produce medical devices for U.S. patients with dialysis and diabetes needs. The Greenville facility will help stabilize Nipro’s U.S. supply chain, as well as reduce global transportation needs and cut carbon emissions.

North America Needle Market coverage (By Value)

  • Type Insight and Forecast 2025 - 2030
    • Conventional
    • Safety
    • Bevel
    • Blunt fill
    • Filter
    • Vented
    • Active
    • Passive
  • Product Insight and Forecast 2025 - 2030
    • Suture
    • Blood
    • Ophthalmic
    • Dental
    • Insufflation
    • Pen
    • Others
  • Material Insight and Forecast 2025 - 2030
    • Glass
    • Plastic
    • Stainless Steel
    • Polyether Ether Ketone
  • Delivery Mode Insight and Forecast 2025 - 2030
    • Hypodermic
    • Intravenous
    • Intramuscular
    • Intraperitoneal
    End-User Insight and Forecast 2025 - 2030
    • Hospitals
    • Diagnostic Center
    • Home Healthcare
    • Others

Geographical Segmentation

North America Needle Market by Region

  • US
  • Canada
  • Mexico